ELOXX PHARMACEUTICALS INC

Q2 2026 13F Holders

Symbol: ELOX
CUSIP: 29014R301
Type: Equity
Class: COM NEW
Num filings: 23
Total reported value, excl. options: $40.2 M

Compare 2026 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type